This compound is primarily utilized in biomedical research to study cellular signaling pathways, particularly those involving TAK1 and MAP4K2 kinases. It is employed to inhibit these kinases, enabling researchers to investigate their roles in inflammation, immune responses, and cancer progression. By blocking TAK1 and MAP4K2 activity, it helps elucidate their contributions to diseases such as rheumatoid arthritis, fibrosis, and certain malignancies. Additionally, it serves as a tool in drug discovery efforts aimed at developing targeted therapies for conditions driven by dysregulated kinase signaling. Its application is critical in preclinical studies to assess potential therapeutic efficacy and safety profiles of new treatments.